ScholarIQanswers from OpenAlex

Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients

PaperCitations, authors & open-access status

Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients have?

ScholarIQcitation count

Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients has 40 citations in the OpenAlex counts ScholarIQ stores.

When was Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients published?

ScholarIQyear

Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients has 2018 year in the ScholarIQ index.

What is the open-access status of Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients?

ScholarIQoa status

Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients has closed oa status in the ScholarIQ index.

What is the DOI of Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients?

ScholarIQdoi

The DOI for Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients is on the source record.

What is the PMID of Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients?

ScholarIQpmid

The PMID for Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients is on the source record.

What is the OpenAlex record for Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients?

ScholarIQopenalex

The OpenAlex for Anaplastic thyroid carcinoma in Denmark 1996–2012: A national prospective study of 219 patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial